NEU-411 is a small molecule that functions as a LRRK2 kinase inhibitor. It targets the LRRK2 (leucine-rich repeat kinase 2) protein, which is involved in Parkinson's disease progression. By inhibiting LRRK2 kinase activity, NEU-411 aims to slow disease progression.
Similar to NEU-411, NEU-723 is a small molecule that also acts as a LRRK2 kinase inhibitor. It targets the LRRK2 protein to inhibit its kinase function, which may reduce the neurodegenerative processes associated with Parkinson's disease.
